Using technology to personalize Onychomycosis treatment.
About Us
Onicor is a dynamic company with a strong team. Together with our leading industry and pioneering academic partners Onicor is developing a personalized treatment for Onychomycosis.
Meet the Team
-
Ronald van der Geest
FOUNDER, CDO
Ronald van der Geest, PhD, is Co-Founder and partner at 3D-PharmXchange, CDO at Treeway and has over 25 years of experience in clinical development.
-
Oscar van Loosbroek
CEO
Oscar van Loosbroek, MSc, has a broad range of experience fulfilling commercial and development roles at small and large pharmaceutical companies in 5 different countries.
-
Luke Fleuren
PRODUCT ENGINEER
Luke Fleuren, MSc, has a background in Biomedical Engineering from the Technical University of Eindhoven, with a specialisation in personalised 3D printed implants.
Advisors
-
Peter Mercelis
STRATEGIC ADVISOR
Peter Mercelis, PhD, is a serial-entrepreneur, investor, and engineer. Having founded and successfully sold multiple businesses in the space of 3D-printing, IT, and medical devices. Peter is on the board of multiple high-tech companies.
-
Jan Schrooten
TECHNOLOGIC ADVISOR
Jan Schrooten, PhD, is a widely published academic and engineer in the field of 3D-printing. Jan is the CEO of Antleron, which develops technology for advanced personalised and regenerative therapies and has over 25 years of experience in the academic and entrepreneurial space.
-
Paul Verweij
SCIENTIFIC ADVISOR
Paul Verweij, Prof, PhD, is a professor and the current chairman of the Medical Microbiology department at Radboud University Medical Center and has over 25 years of experience in mycology, pharmacology, and medical microbiology.
-
Willem Melchers
SCIENTIFIC ADVISOR
Willem Melchers, PhD, is an associate professor in Molecular Microbiology at Radboud University Medical Center and general manager lab operations at MDxHealth and has over 25 years of experience in entrepreneurship and medical microbiology.
Partners
Funded by
Eurostars | RVO
